SIRT1 may act as a tumor promoter or suppressor, depending on the tumor type, as its overexpression inhibits tumorigenesis in colon tumors and ovarian cancer [31, 32], but stimulates tumorigenesis in prostate tumors and acute myeloid leukemia [11, 33]. Here, SIRT1 is linked to ovarian carcinoma.